{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:05:59Z","timestamp":1776755159887,"version":"3.51.2"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T00:00:00Z","timestamp":1169078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2007,3]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To determine the relationship between hydroxymethyl glutaryl coenzyme A reductase inhibitor (statin) use and proximal muscle strength, cognition, and depression in older adults.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Observational cohort study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Outpatient primary care clinics.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    Seven hundred fifty\u2010six community\u2010dwelling veterans aged 65 and older.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    Timed chair stands (a measure of proximal muscle strength), Trail Making Test Part B (a measure of cognition), and the Center for Epidemiologic Studies Depression Scale score were measured at baseline and 1\u2010year follow\u2010up. Participants were assessed for statin prescriptions (and indications for or contraindications to their use), concomitant medication use, comorbidities, and other potential confounders.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Statin users (n=315) took a mean 6.6 medications, versus 4.6 for nonusers (n=441), and had a median duration of statin use of 727 days. Statin users were more likely to be white and had (as expected) more cardiac, cerebrovascular, and peripheral vascular disease. Based on multivariable models adjusting for pertinent covariates, statin users performed modestly better than nonusers for timed chair stands (\u22120.5 seconds;\n                    <jats:italic>P=<\/jats:italic>\n                    .04), Trail Making Test Part B (\u22127.7 seconds;\n                    <jats:italic>P=<\/jats:italic>\n                    .08), and depression scores (\u22120.2 points;\n                    <jats:italic>P=<\/jats:italic>\n                    .49) at follow\u2010up. Of potentially high\u2010risk participants (based on age, comorbidity, and number of medications), statin users also showed similar 1\u2010year changes as nonusers, although worsened depression scores were found in those with greater comorbidity (+0.88 points;\n                    <jats:italic>P=<\/jats:italic>\n                    .10).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Older, community\u2010dwelling male participants taking maintenance statin therapy had similar outcomes to those of nonusers in tests of muscle strength, cognition, and depression, but further examination of benefits and harms in different subgroups is warranted.\n                  <\/jats:p>","DOI":"10.1111\/j.1532-5415.2007.01071.x","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T17:31:06Z","timestamp":1169141466000},"page":"420-425","source":"Crossref","is-referenced-by-count":87,"title":["Effects of Statin Use on Muscle Strength, Cognition, and Depressive Symptoms in Older Adults"],"prefix":"10.1111","volume":"55","author":[{"given":"Joseph V.","family":"Agostini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Tinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"McAvay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnne M.","family":"Foody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Concato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe048061"},{"key":"e_1_2_6_3_2","first-page":"2902","article-title":"Statins in stroke prevention and carotid atherosclerosis","volume":"35","author":"Amarenco P","year":"2004","journal-title":"Systematic review and up-to-date meta-analysis"},{"key":"e_1_2_6_4_2","first-page":"77","article-title":"The pros and cons of lipid lowering in octogenarians","volume":"1","author":"Agostini JV","year":"2005","journal-title":"Issues in clinical decision making"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000034125.94759.41"},{"key":"e_1_2_6_6_2","first-page":"215","article-title":"Prescription of statins to dyslipidemic patients affected by liver diseases","volume":"14","author":"Anfossi G","year":"2004","journal-title":"A subtle balance between risks and benefits"},{"issue":"23","key":"e_1_2_6_7_2","first-page":"III50","article-title":"Safety of statins","volume":"109","author":"Bellosta S","year":"2004","journal-title":"Focus on clinical pharmacokinetics and drug interactions"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03167690"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A289"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/85.5.459"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00009"},{"key":"e_1_2_6_12_2","first-page":"726","article-title":"The role of lipid\u2010lowering drugs in cognitive function","volume":"23","author":"Etminan M","year":"2003","journal-title":"A meta-analysis of observational studies"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.07.041"},{"key":"e_1_2_6_14_2","first-page":"871","article-title":"Statin\u2010associated memory loss","volume":"23","author":"Wagstaff LR","year":"2003","journal-title":"Analysis of 60 case reports and review of the literature"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00353-3"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.177.1.77"},{"key":"e_1_2_6_17_2","first-page":"309","article-title":"Lowering cholesterol concentrations and mortality","volume":"301","author":"Muldoon MF","year":"1990","journal-title":"A quantitative review of primary prevention trials"},{"key":"e_1_2_6_18_2","first-page":"649","article-title":"Serum cholesterol concentration and death from suicide in men","volume":"313","author":"Zureik M","year":"1996","journal-title":"Paris prospective study I"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.3.259"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.4.437"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/57.11.M727"},{"key":"e_1_2_6_22_2","first-page":"373","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies","volume":"40","author":"Charlson ME","year":"1987","journal-title":"Development and validation"},{"key":"e_1_2_6_23_2","volume-title":"Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures","author":"Fillenbaum G.","year":"1988"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2003.51104.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503023320902"},{"key":"e_1_2_6_26_2","volume-title":"The Halstead\u2010Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation","author":"Reitan RM","year":"1993"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/089826439300500202"},{"key":"e_1_2_6_28_2","first-page":"385","article-title":"The CES\u2010D scale","volume":"1","author":"Radloff LS.","year":"1977","journal-title":"A self-report depression scale for research in the general population"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563"},{"key":"e_1_2_6_30_2","first-page":"39","article-title":"Demographic characteristics and normative observations for derived\u2010trail making test indices","volume":"15","author":"Drane DL","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.16.1926"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7049.75"},{"key":"e_1_2_6_33_2","first-page":"178","article-title":"The UCSD Statin Study","volume":"25","author":"Golomb BA","year":"2004","journal-title":"A randomized controlled trial assessing the impact of statins on selected noncardiac outcomes"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","DOI":"10.1037\/10259-000","volume-title":"Lipids, Health, and Behavior","author":"Hillbrand M","year":"1997"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.3.389"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2007.01071.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2007.01071.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:55:27Z","timestamp":1762188927000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2007.01071.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["10.1111\/j.1532-5415.2007.01071.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01071.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}